Nothing Special   »   [go: up one dir, main page]

Morimoto et al., 1998 - Google Patents

Co-injection of β-amyloid with ibotenic acid induces synergistic loss of rat hippocampal neurons

Morimoto et al., 1998

Document ID
1321381117817710720
Author
Morimoto K
Yoshimi K
Tonohiro T
Yamada N
Oda T
Kaneko I
Publication year
Publication venue
Neuroscience

External Links

Snippet

Senile plaques are a pathological hallmark of Alzheimer's disease. The major component of senile plaques is β-amyloid which consists of approximately 4000 mol. wt of peptide. Accumulating evidence suggests that β-amyloid may represent the underlying cause of …
Continue reading at www.sciencedirect.com (other versions)

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/07—Tetrapeptides

Similar Documents

Publication Publication Date Title
Morimoto et al. Co-injection of β-amyloid with ibotenic acid induces synergistic loss of rat hippocampal neurons
Saito et al. Taxifolin inhibits amyloid-β oligomer formation and fully restores vascular integrity and memory in cerebral amyloid angiopathy
Kubo et al. In vivo conversion of racemized β‐amyloid ([D‐Ser26] Aβ1–40) to truncated and toxic fragments ([D‐Ser26] Aβ25–35/40) and fragment presence in the brains of Alzheimer's patients
Celsi et al. Mitochondria, calcium and cell death: a deadly triad in neurodegeneration
Masters et al. Molecular mechanisms for Alzheimer's disease: implications for neuroimaging and therapeutics
Castellani et al. Alzheimer disease
Bouter et al. N-truncated amyloid β (Aβ) 4-42 forms stable aggregates and induces acute and long-lasting behavioral deficits
Shukla et al. A truncated peptide from p35, a Cdk5 activator, prevents Alzheimer's disease phenotypes in model mice
Saido et al. Metabolism of amyloid β peptide and pathogenesis of Alzheimer's disease: towards presymptomatic diagnosis, prevention and therapy
Krstic et al. Deciphering the mechanism underlying late-onset Alzheimer disease
Tran et al. Controlled cortical impact traumatic brain injury in 3xTg-AD mice causes acute intra-axonal amyloid-β accumulation and independently accelerates the development of tau abnormalities
Koo et al. Precursor of amyloid protein in Alzheimer disease undergoes fast anterograde axonal transport.
Stackman et al. Prevention of age-related spatial memory deficits in a transgenic mouse model of Alzheimer's disease by chronic Ginkgo biloba treatment
Frautschy et al. Protease inhibitor coinfusion with amyloid β-protein results in enhanced deposition and toxicity in rat brain
Sivilia et al. Multi-target action of the novel anti-Alzheimer compound CHF5074: in vivo study of long term treatment in Tg2576 mice
Hu et al. The impact of Aβ-plaques on cortical cholinergic and non-cholinergic presynaptic boutons in Alzheimer's disease-like transgenic mice
Hiltunen et al. Functional roles of amyloid-β protein precursor and amyloid-β peptides: evidence from experimental studies
Chui et al. Apoptotic neurons in Alzheimer's disease frequently show intracellular Aβ42 labeling
Ding et al. Indirubin-3'-monoxime rescues spatial memory deficits and attenuates β-amyloid-associated neuropathology in a mouse model of Alzheimer's disease
Dodart et al. The β-amyloid precursor protein and its derivatives: from biology to learning and memory processes
Kato et al. Prevention of amyloid-like deposition by a selective prolyl endopeptidase inhibitor, Y-29794, in senescence-accelerated mouse
Tong et al. Targeting Alzheimer’s disease neuro-metabolic dysfunction with a small molecule nuclear receptor agonist (T3D-959) reverses disease pathologies
Miguel-Hidalgo et al. β-Amyloid (1–40)-induced neurodegeneration in the rat hippocampal neurons of the CA1 subfield
Bereczki et al. Overexpression of human apolipoprotein B-100 induces severe neurodegeneration in transgenic mice
Wang et al. Effect of rosiglitazone on amyloid precursor protein processing and Aβ clearance in streptozotocin-induced rat model of Alzheimer’s disease